Spiriva® Assessment of FEV1 (SAFE)

NCT00277264 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

914

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium (Spiriva®)

Sponsor

Boehringer Ingelheim